Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Shreveport-Bossier City, LA MSA — September 2026
Shreveport regulatory pay slides as national scarcity deepens.
Shreveport's Regulatory Affairs Specialist advertised pay fell to $98,612 against a flat $104,000 national median, even as Director-level regulatory talent nationally commands up to $580K amid acute scarcity.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Metro Regulatory Affairs pay: $98,612 — Down moderately vs stable $104,000 national
- Metro unemployment rate: 4.3% — Matches August 2025 reading; stable
- Louisiana pharma manufacturing employment: 79 workers — Declining 10.4% annually statewide
- Metro CRA advertised pay: $79,557 — Up significantly, trailing $90,956 national
Key takeaways
Regulatory pay is falling locally while scarcity rises nationally.
Shreveport's Regulatory Affairs Specialist advertised median dropped to $98,612 against a flat national $104,000, a divergence that runs counter to national signals of acute regulatory talent shortages tied to EU MDR and FDA pathway changes. Local employers may be underpricing a function national data identifies as a strategic bottleneck.
CRA pay surged locally, outpacing most other roles tracked.
Clinical Research Associate advertised pay rose significantly to $79,557 in metro, tracking the 15.1% national surge in life sciences postings Q1-to-Q2 2026. Rising CRA demand locally may reflect expanded clinical trial activity or CRO staffing needs that could tighten further as national postings keep climbing.
Manufacturing infrastructure gap forces outsourcing by default.
With only 79 generic pharmaceutical manufacturing workers statewide and that figure declining 10.4% annually, Louisiana lacks the CMC and manufacturing talent density to support internal build strategies at scale. CDMO partnerships look less like a strategic choice and more like the only viable path for Shreveport-based manufacturing scale-up.
Biostatistician pay stability may mask a deeper sourcing problem.
Metro Biostatistician pay held stable at $128,494, close to the $133,322 national median, suggesting local employers aren't yet forced to bid up for this specialty. Flat pay in a thin local talent pool may signal reliance on remote hires rather than genuine local market balance — worth confirming before assuming parity with coastal hubs.
Median advertised pay by role — Shreveport-Bossier City, LA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $82,152 | $132,964 | $150,000 | Significant increase | $131,354 |
| Clinical Research Associate | $52,489 | $79,557 | $93,892 | Significant increase | $90,956 |
| Lab Technician * | $39,780 | $45,760 | $51,465 | Moderate decline | $47,402 |
| Regulatory Affairs Specialist * | $72,732 | $98,612 | $116,373 | Moderate decline | $104,000 |
| Clinical Data Manager * | $96,750 | $127,578 | $142,800 | Moderate decline | $123,031 |
| Biostatistician * | $107,702 | $128,494 | $155,013 | Stable | $133,322 |
| Validation Engineer * | $97,024 | $165,360 | $172,800 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Shreveport-Bossier's 4.3% unemployment rate and Caddo Parish's flat employment growth (-0.7% YoY through March 2026) reflect a metro economy still absorbing manufacturing contraction while Schlumberger's 800-employee expansion and the Cyber Research Park signal selective sector growth outside life sciences entirely. Wage growth locally (3.7% in Caddo Parish) continues to trail inflation-adjusted national benchmarks, and the metro's $26.24 average hourly wage against the $33.54 national figure underscores a structural pay gap that complicates recruiting specialized scientific talent from larger hubs.
What it means
Generic pharmaceutical manufacturing employment in Louisiana has declined to just 79 workers statewide, confirming that build-vs-outsource decisions for manufacturing and CMC functions increasingly favor CDMO partnerships over local infrastructure investment, particularly as national Director CMC/Process Development compensation reaches $220K-$520K and outpaces what Shreveport-area budgets can sustain. Regulatory Affairs Specialist advertised pay fell 5.5 points locally even as national postings hold stable, suggesting Shreveport employers may be losing ground in a function national data shows is critically tight — Director Regulatory Affairs roles command $320K-$580K nationally and take 10-16 weeks to fill in comparable clinical-stage organizations. Consider reviewing regulatory affairs compensation positioning against national trajectories before the gap signals to candidates that remote-first hubs offer better career economics than metro-based roles.
Looking ahead
Worth watching: Caddo Parish employment contracted 0.7% year-over-year even as wages grew 3.7%, an unusual combination worth tracking for whether it reflects selective specialist hiring amid broader headcount caution. Life sciences employers should watch whether this pattern extends to scientific and regulatory roles specifically.
Emerging pressure point: Regulatory Affairs Specialist advertised pay has moved down moderately in Shreveport against a stable national trend, a divergence that could widen if national regulatory talent scarcity intensifies through Q4. Monitor whether this creates retention risk for any regulatory staff with multi-market experience.
Expected: Louisiana's September unemployment insurance claims ran roughly 30% below 2025 levels, consistent with a stabilizing labor market that may reduce candidate flow for life sciences employers competing against manufacturing and energy-sector wage growth in the metro.
Early indicator: National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions while execution-critical roles stay open — watch whether any displaced regulatory or clinical talent surfaces in the Shreveport market as remote-capable candidates, given the metro's existing pay discount.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.